Cannabis News

TSX Cannabis Stocks – Cannabis Hemp Blog

The cannabis trade has grown in recent years, and with the potential for legalization of recreational use on the horizon for Canada, companies have been able to enter the big leagues of stock trading by taking listing on the Toronto Stock Exchange (TSX).

The TSX has seen cannabis industry leaders join its roster and offer investors a new venue for cannabis businesses. These include huge license producers (LPs) that are expanding their products and brands overseas.

These companies are industry leaders with their rapid growth and ability to rank on the TSX. They are leading in terms of large-scale developments and means of cannabis production.

Here, Investing News Network (INN) offers investors a growing list of all cannabis-related companies listed on the TSX.

Looking for cannabis stocks?

Read our report to find market data, important news and stocks to watch!

Aphria (TSX:HPA)

Also licensed under the ACMPR, just like other Canadian marijuana stock companies, Aphria is located in Leamington, Ontario. The company describes itself as “truly powered by sunlight,” which it says enables natural growing conditions to produce safe medical cannabis products.

Aphria has made its strategy entry into the US cannabis market by Liberty Health Sciences (CSE:LHS; OTCBB:LHSIF), which seeks out and partners with cannabis companies in the United States. Their first market is in Florida. Despite its interest in the US market, the company was forced to sell its assets south of the border due to regulatory issues with TMX Group. Aphria has sold its stake in an Arizona producer to Liberty Health and plans to divest its own stake in Liberty Health.

The company recently expanded their international reach thanks to a major $826 million acquisition for Nuuvera (TSXV:NUU).

Aurora Cannabis (TSX:ACB)

Next on our Canadian cannabis stocks is Aurora Cannabis. This company is currently working rapidly on the development of its Aurora Sky facility, an 800,000 square foot hybrid greenhouse, which has obtained its cultivation license from Health Canada, the country’s regulatory body.

As part of its latest quarterly update to shareholders, the company disclosed that it had reached $11.7 million of revenue for the second quarter of their fiscal year 2018. The company also shared some details about one of its most recent partnerships, an investment deal with Liquor Stores NA to plan the establishment of outlets cannabis retail.

The company explained that its new investor will convert existing outlets into cannabis-specific outlets while looking for new spaces to develop.

On May 1, the company completed its acquisition of CanniMed Therapeutics and managed the company’s delisting as she became an asset to Aurora.

Today, the company continues its acquisition path by announcing an agreement for purchase MedReleaf (TSX:LEAF). The deal is worth more than C$3 billion to purchase all of the issued and outstanding common shares of MedReleaf.

Looking for cannabis stocks?

Read our report to find market data, important news and stocks to watch!

CannTrust Holdings (TSX:TRST)

CannTrust became the sixth LP to join the TSX when its shares officially launched on the First Canadian Exchange on March 5. The company completely ignored the TSX Venture Exchange and switched from the Canadian Securities Exchange (CSE).

“Our move to the TSX reflects the incredible progress we have made since listing on the CSE in August last year and represents another significant milestone for CannTrust as we continue our successful journey as one of the from Canada leading cannabis companies » Eric Paulsaid the CEO of CannTrust.

This year CannTrust managed to finish a $15,000,000 mortgage financing agreement for its greenhouse in Niagara.

Canopy growth (TSX:GRASS)

Canopy Growth is Canada’s largest cannabis stock, having been the first cannabis organization to exceed $1 billion in market capitalization.

Canopy holds growers Tweed and Bedrocan under its umbrella. Tweed’s production facility is located in the former Hershey factory in Smith Falls, Ontario, while its breeding facility was completed in September 2016. The company believes the state-of-the-art facility is the first of its kind and will form the basis of new Canadian genetics.

Canopy regularly announces new agreements and partnerships with international emerging markets. At the end of 2017, the company announced a deal that sent a signal to the entire industry. Constellation Brands (NYSE:ZST), a major alcohol producer in the United States, invested in 9.9% of Canopy’s shares, which signaled the increased credibility of the cannabis business in the global market.

In line with Cronos Group (NASDAQ:CRON), Canopy announced its intention to list on the New York Stock Exchange. The company will trade in the United States under the symbol “CGC”.

MedReleaf (TSX:LEAF)

MedReleaf is one of the Canadian cannabis stocks whose company strives to advance the available knowledge about the therapeutic benefits of cannabis for patient care. At the Canaccord Cannabis Investor Day Conference, they revealed throughout 2018 that their top four areas of focus included the Canadian medical cannabis market and opportunities in the international market.

The company was rumored to be starting a process to let players know the company was available for the taking. The rumors were later confirmed once an acquisition deal with Aurora Cannabis was announced.

Launched publicly this year, this company counts with the support of the great Canadian producer Aurora Cannabis, even appointing Cam Battley, general manager of Aurora, to the board of directors of TGOD.

The company was able to close its initial public offering with gross proceeds of $132,263,225 from the IPO thanks in part to the issuance of 36,236,500 additional units of the company, including over-allotment units to financial institutions.

“Aurora Cannabis’ additional investments…both in the IPO and in the over-allotment option brings Aurora’s total investment in the company to $78,145,562 and further validates the business plan and the value of TGOD,” said Robert Anderson, Co-Chairman and CEO of TGOD in a statement. .

Did we miss a company that you think should be on the list of marijuana stocks in Canada? Let us know in the comments!

Don’t forget to follow us @INN_Cannabis for real-time updates!

Securities Disclosure: I, Bryan McGovern, have no direct investment interests in any of the companies mentioned in this article.

Editorial Disclosure: The Green Organic Dutchman is a client of the Investing News Network. This article is not paid content.

Looking for cannabis stocks?

Read our report to find market data, important news and stocks to watch!

The post TSX Cannabis Stocks appeared first on Investment News Network.


#TSX #Cannabis #Stocks #Cannabis #Hemp #Blog

Related Posts

Leave a Reply